Exigência - art. 36 da LPI
#6.1
06/23/2026
RPI 2894
Application data
Number
112020004856Type
Filing
Publication
PCT
AU2018050937 The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).
Deadline to answer the office action:09/21/2026(28 days left)
Latest action published by the INPI: 06/23/2026. We update with every new RPI gazette, published weekly.
Applicants
CYNATA THERAPEUTICS LIMITED
AU
Inventors
C. S. (pessoa física)
AU
S. R. (pessoa física)
AU
IPC Classification
Priority claims
AU
2017903758 · 09/15/2017
Abstract
A invenção se refere ao uso de uma célula-tronco mesenquimal derivada de mesênquima angioblástico (MSC-MSC) para tratar doença alérgica das vias aéreas (AAD)/asma em um indivíduo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.1
06/23/2026
RPI 2894
#6.23
03/06/2025
RPI 2826
#15.35
11/23/2021
RPI 2655
#1.3
09/15/2020
RPI 2593
#1.1
03/24/2020
RPI 2568
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.